Riskpilot← Back to searchSign inGet full accessFET LEGESENTER AS
ASActiveOrg 980889823Gamle Fetvei 13, 1900 FetsundOther human health activities n.e.c. · NACE 8699Est. 19996 employees
Revenue 2024
NOK 7,7M
+16% vs 2023
EBITDA margin
6.3%
+388% vs 2023
Equity ratio
44.7%
Financial strength
Net profit 2024
NOK 422K
+330% vs 2023
| Revenue | NOK 7,7M | +16% |
| EBITDA | NOK 486K | +388% |
| Net profit | NOK 422K | +330% |
| Total assets | NOK 1,8M | +29% |
| Equity | NOK 793K | +114% |
| Employees | 6 | — |
Legal name
FET LEGESENTER AS
Org number
980889823
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
1. juni 1999
Share capital
—
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Legevirksomhet og andre produkter/tjenester som naturlig hører sammen med dette, investering og utleie, samt deltakelse i annen virksomhet.
Address
Gamle Fetvei 13, 1900 Fetsund
Phone
+4763887820
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 682 | 6 079 | 5 980 | 6 624 | 7 680 |
| Staff expenses | −3 038 | −3 237 | −2 830 | −3 482 | −3 677 |
| EBITDA | 117 | 365 | 16 | −169 | 486 |
| Depreciation & amort. | −111 | −100 | −39 | −20 | −25 |
| EBIT | 6 | 265 | −24 | −188 | 461 |
| Net financials | −32 | 4 | 4 | 5 | 6 |
| Profit before tax | −25 | 269 | −19 | −183 | 467 |
| Tax | −0 | 23 | −0 | −0 | 45 |
| Net profit | −25 | 246 | −19 | −183 | 422 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 086 | 1 558 | 1 581 | 1 376 | 1 775 |
| Equity | 328 | 574 | 555 | 372 | 793 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 758 | 985 | 1 026 | 1 004 | 982 |
| Total debt | 758 | 985 | 1 026 | 1 004 | 982 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20202024
Equity ratio
44.7%
This company
38.2%
Market median
+17% vs market
20202024
Return on equity
53.2%
This company
18.4%
Market median
+189% vs market
20202024
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20202024
Asset turnover
4.33×
This company
1.12×
Market median
+287% vs market
20202024
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2023 | |
| Former (1) | ||
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 18.2% | 18.2% | 2022 | |
| Individual | 18.2% | 18.2% | 2022 | |
| Individual | 18.2% | 18.2% | 2022 | |
| Individual | 18.2% | 18.2% | 2022 | |
| Individual | 18.1% | 18.1% | 2022 | |
| Individual | 9.1% | 9.1% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FET LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Solveig Kristine Kolstad Torvund | Board of Directors | 0 companies |
| Maria Fjellvang Karlsrud | Board of Directors | 0 companies |